IFNG and neoplasm: These studies demonstrated that, compared to unarmored CAR T-cells, membrane-bound IL-12-CAR T-cells released more IFN-γ, and demonstrated superior anti-tumor efficacy in murine models of solid tumors, including large established tumors, without inducing systemic toxicity.